CBU
BEAM icon

CIBC Bancorp USA’s Beam Therapeutics BEAM Stock Holding History

CIBC Bancorp USA’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$247K Buy
+10,192
New +$203K ﹤0.01% 1167

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIBC Bancorp USA's BEAM Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Beam Therapeutics (BEAM) in Q3 2025: 10,192 shares worth $247K. The stake represents ﹤0.01% of the portfolio and ranks #1167 among its holdings.

218 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • CIBC Bancorp USA held 10,192 shares of Beam Therapeutics worth $247K as of Q3 2025.
  • Beam Therapeutics was a new CIBC Bancorp USA position in Q3 2025.
  • Beam Therapeutics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1167 holding.
  • 218 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.